Abstract
No public abstract is available from the verified source records.
Clare Nimura, Lisbel Gonzalez, Sharl Azar, Alexander Boucher, Seethal A. Jacob, Kristine Karkoska, Layla Van Doren, Maayan Leroy‐Melamed, Patrick T. McGann
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Population Estimates of Sickle Cell Disease in the U.S
10.1016/j.amepre.2009.12.022 · 2010
Global, Regional, and National Prevalence and Mortality Burden of Sickle Cell Disease, 2000‐2021: A Systematic Analysis From the Global Burden of Disease Study 2021
10.1016/s2352-3026(23)00118-7 · 2023
Unresolved referenced work
2023
Gene Therapy in Sickle Cell Disease: Attitudes and Informational Needs of Patients and Caregivers
10.1002/pbc.30319 · 2023
Listening to Patients and Parents With Sickle Cell Disease: The Totality of Gene Therapy Risks May Outweigh the Perceived Benefits
10.1182/bloodadvances.2024012963 · 2024
Preferences for Potential Benefits and Risks for Gene Therapy in the Treatment of Sickle Cell Disease
10.1182/bloodadvances.2023009680 · 2023
Current and Future Treatments for Sickle Cell Disease: From Hematopoietic Stem Cell Transplantation to In Vivo Gene Therapy
10.1016/j.ymthe.2025.03.016 · 2025
Mobilization Meets Antibody Conditioning: A Path Toward Safer Engraftment
10.1016/j.ymthe.2025.09.018 · 2025
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No additional external references are available.